Next Article in Journal
Elevated TAT in COVID-19 Patients with Normal D-Dimer as a Predictor of Severe Respiratory Failure: A Retrospective Analysis of 797 Patients
Next Article in Special Issue
Expression of Iron Metabolism Proteins in Patients with Chronic Heart Failure
Previous Article in Journal
Organizational E-Readiness for the Digital Transformation of Primary Healthcare Providers during the COVID-19 Pandemic in Poland
Previous Article in Special Issue
Blood Differential Gene Expression in Patients with Chronic Heart Failure and Systemic Iron Deficiency: Pathways Involved in Pathophysiology and Impact on Clinical Outcomes
 
 
Review
Peer-Review Record

Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology

by Ridha I. S. Alnuwaysir, Martijn F. Hoes, Dirk J. van Veldhuisen, Peter van der Meer and Niels Grote Beverborg *
Reviewer 1:
Reviewer 2: Anonymous
Submission received: 25 November 2021 / Revised: 17 December 2021 / Accepted: 22 December 2021 / Published: 27 December 2021

Round 1

Reviewer 1 Report

In this work, the authors extensively reviewed the mechanism, pathophysiology, and clinical implications of iron deficiency in HF. The authors should be congratulated for this impressive, comprehensive, and updated work. 

Just minor comments.

  1. There are minor typo errors (for instance, line 48).
  2. I would expand the data (pro/cons) about the adequacy of ESC ID definition in HF. As commented by the authors this definition is somewhat arbitrary. 
  3. I would summarize the most important and current "gaps in the knowledge" in a new figure or table. 
  4. The authors should also mention new lines of research

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

The authors have conducted an extensive and comprehensive review of iron deficiency and its impact on heart failure. It can also be appreciated that the authors correlate both the basic science and clinical presentation of ID as it affects HF. They also take the review a step further and highlight how ID in other organs affects HF patients. The authors also cite major trials that have addressed or are addressing the lack of data on this topic. I commend the authors on their excellent manuscript.

Author Response

Thank you very much for your kind words.  We really appreciate you taking the time out to review our manuscript. 

Back to TopTop